Are you suggesting that PBMs are going to favor Pradaxa for AF even when Xarelto and Eliquis are approved in this indication (as they inevitably will be)?
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”